We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Foreign Discovery Mostly Denied In Zofran Birth Defect MDL

Law360, Boston (August 25, 2017, 1:29 PM EDT) -- A Massachusetts federal judge on Thursday mostly rejected efforts by families suing GlaxoSmithKline over alleged links between birth defects and anti-nausea drug Zofran to get access to foreign regulatory files.

The families had said the request could shed light on whether GSK misled the U.S. Food and Drug Administration by comparing what they told American regulators to what they told regulators in Japan, the U.K. and Canada.

U.S. Magistrate Judge Judith Dein said at a hearing that she was mostly going to reject the request but...
To view the full article, register now.




Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number




Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability


F. Dennis Saylor, IV

Date Filed

October 13, 2015

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.